C

Cellectis SA

D
CLLS
USD
-0.07
(-3.5714%)
Market Closed
616.00
حجم التداول
-0.95091
الربح لكل سهم
-
العائد الربحي
-1.542439
P/E
189,176,970.15
حجم السوق
اليوم
-3.5714%
1 اسبوع
9.249%
1 شهر
-3.077%
6 اشهر
-38.033%
12 اشهر
-25.882%
بداية السنة
-37.829%
كل الوقت
0%
avatar
sara abdelazim
عدد النقاط
112
عدد التوصيات
2

Title:
Cellectis SA

Sector:
Healthcare
Industry:
Biotechnology
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC, product candidates in other therapeutic indications.
هل تحتاج مساعدة او لديك استفسار؟